X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (40765) 40765
Newsletter (2370) 2370
Newspaper Article (1070) 1070
Book Chapter (257) 257
Magazine Article (218) 218
Dissertation (184) 184
Publication (43) 43
Book / eBook (40) 40
Conference Proceeding (36) 36
Government Document (33) 33
Transcript (22) 22
Web Resource (21) 21
Reference (11) 11
Book Review (4) 4
Journal / eJournal (3) 3
Paper (3) 3
Report (2) 2
Streaming Video (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (24891) 24891
erythropoietin (22785) 22785
male (12144) 12144
female (11536) 11536
animals (11387) 11387
anemia (8472) 8472
erythropoietin - therapeutic use (7823) 7823
middle aged (6802) 6802
adult (6245) 6245
mice (5474) 5474
recombinant proteins (5124) 5124
aged (5056) 5056
recombinant-human-erythropoietin (4913) 4913
erythropoietin - pharmacology (4901) 4901
hematology (4593) 4593
urology & nephrology (4347) 4347
anemia - drug therapy (4198) 4198
anemia - etiology (4070) 4070
erythropoietin - administration & dosage (3475) 3475
rats (3429) 3429
research (3345) 3345
erythropoietin - blood (3215) 3215
erythropoiesis (2860) 2860
expression (2684) 2684
hematocrit (2677) 2677
oncology (2565) 2565
erythropoietin - metabolism (2486) 2486
biochemistry & molecular biology (2465) 2465
renal dialysis (2397) 2397
hemoglobin (2349) 2349
kidney failure, chronic - complications (2315) 2315
hypoxia (2289) 2289
kidney failure, chronic - therapy (2170) 2170
treatment outcome (2166) 2166
analysis (2138) 2138
time factors (2092) 2092
hemodialysis (2085) 2085
cells, cultured (2050) 2050
anemia - blood (2040) 2040
pharmacology & pharmacy (1925) 1925
hemoglobins - analysis (1918) 1918
cancer (1864) 1864
medicine, research & experimental (1839) 1839
therapy (1833) 1833
recombinant proteins - therapeutic use (1832) 1832
epoetin alfa (1797) 1797
apoptosis (1781) 1781
medicine, general & internal (1779) 1779
transplantation (1777) 1777
care and treatment (1768) 1768
erythropoietin - adverse effects (1725) 1725
cell biology (1720) 1720
cells (1696) 1696
erythropoietin - genetics (1644) 1644
hemoglobins - metabolism (1599) 1599
health aspects (1574) 1574
aged, 80 and over (1551) 1551
erythropoietin - biosynthesis (1537) 1537
adolescent (1531) 1531
erythropoietin receptor (1529) 1529
erythropoiesis - drug effects (1527) 1527
blood transfusion (1513) 1513
anemia - therapy (1509) 1509
hematinics - therapeutic use (1501) 1501
mortality (1499) 1499
risk factors (1498) 1498
erythropoietin, recombinant (1484) 1484
dose-response relationship, drug (1469) 1469
disease (1384) 1384
signal transduction (1383) 1383
cell line (1371) 1371
proteins (1353) 1353
surgery (1352) 1352
hemodialysis-patients (1336) 1336
iron (1315) 1315
physiological aspects (1275) 1275
prospective studies (1257) 1257
receptor (1249) 1249
pediatrics (1238) 1238
activation (1226) 1226
inflammation (1222) 1222
gene expression (1221) 1221
growth factors (1208) 1208
erythropoietin - physiology (1206) 1206
colony-stimulating factor (1198) 1198
infant, newborn (1197) 1197
erythropoietin - analogs & derivatives (1153) 1153
glycoproteins (1151) 1151
anaemia (1122) 1122
kidney failure, chronic - blood (1118) 1118
double-blind (1117) 1117
neurosciences (1109) 1109
blood (1107) 1107
receptors, erythropoietin - metabolism (1081) 1081
retrospective studies (1073) 1073
molecular sequence data (1071) 1071
quality of life (1071) 1071
physiology (1064) 1064
darbepoetin alfa (1054) 1054
chemotherapy (1035) 1035
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (20) 20
Online Resources - Online (18) 18
Collection Dvlpm't (Acquisitions) - Vendor file (3) 3
UofT at Mississauga - Stacks (3) 3
University Archives - Archives (2) 2
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Gerstein Science - Reference (1) 1
Gerstein Science - Theses (1) 1
OISE - Stacks (1) 1
UTL at Downsview - May be requested (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (41525) 41525
German (763) 763
French (755) 755
Japanese (711) 711
Spanish (566) 566
Russian (457) 457
Chinese (298) 298
Polish (297) 297
Italian (238) 238
Portuguese (132) 132
Czech (98) 98
Korean (86) 86
Hungarian (41) 41
Turkish (40) 40
Dutch (31) 31
Croatian (26) 26
Serbian (23) 23
Danish (21) 21
Swedish (16) 16
Bulgarian (15) 15
Norwegian (15) 15
Romanian (14) 14
Persian (12) 12
Finnish (10) 10
Slovak (8) 8
Hebrew (6) 6
Ukrainian (6) 6
Slovenian (5) 5
Arabic (2) 2
Bosnian (2) 2
Lithuanian (2) 2
Icelandic (1) 1
Indonesian (1) 1
Macedonian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Neuroscience, ISSN 0270-6474, 01/2006, Volume 26, Issue 4, pp. 1269 - 1274
Journal Article
Cell (Cambridge), ISSN 0092-8674, 2017, Volume 168, Issue 6, pp. 1053 - 1064.e15
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2013, Volume 368, Issue 13, pp. 1210 - 1219
In this trial, patients with systolic heart failure and anemia were assigned to receive either darbepoetin alfa or placebo. At 28 months, there was no... 
MORTALITY | CONTROLLED-TRIAL | CITY CARDIOMYOPATHY QUESTIONNAIRE | EPOETIN | MORBIDITY | REDUCTION | DOUBLE-BLIND | CHRONIC KIDNEY-DISEASE | MEDICINE, GENERAL & INTERNAL | Shock, Septic - etiology | Double-Blind Method | Heart Failure, Systolic - drug therapy | Hematinics - therapeutic use | Erythropoietin - therapeutic use | Heart Failure, Systolic - mortality | Humans | Middle Aged | Kaplan-Meier Estimate | Proportional Hazards Models | Erythropoietin - adverse effects | Hematinics - adverse effects | Male | Thromboembolism - etiology | Erythropoietin - analogs & derivatives | Stroke - etiology | Anemia - drug therapy | Treatment Failure | Female | Aged | Darbepoetin alfa | Anemia - etiology | Hemoglobins - analysis | Heart Failure, Systolic - complications | Heart failure | Usage | Care and treatment | Anemia | Patient outcomes | Diagnosis | Clinical trials | Patient safety | Hemoglobin | Thromboembolism | Patients | Heart diseases | Cancer | Shock | Systolic/mortality | Hematinics/adverse effects | chronic heart failure | Erythropoietin/analogs & derivatives | Thromboembolism/etiology | Klinisk medicin | Heart Failure | Anemia/drug therapy | Hematinics/therapeutic use | Erythropoietin/therapeutic use | Hemoglobins/analysis | Anemia/etiology | Erythropoietin/adverse effects | Stroke/etiology | Clinical Medicine | Systolic/complications | Septic/etiology | Systolic/drug therapy
Journal Article
Neurotherapeutics, ISSN 1878-7479, 2009, Volume 6, Issue 1, pp. 108 - 127
The growth factor erythropoietin (EPO) and erythropoietin receptors (EPOR) are expressed in the nervous system. Neuronal expression of EPO and EPOR peaks... 
hematocrit | thrombocytes | motor function | Ischemia | cognition | safety | Neurology | Neurosciences | Biomedicine | Neurobiology | Neurosurgery | RECOMBINANT-HUMAN-ERYTHROPOIETIN | ANEURYSMAL SUBARACHNOID HEMORRHAGE | CANCER-ASSOCIATED ANEMIA | FOCAL CEREBRAL-ISCHEMIA | HIGH-DOSE ERYTHROPOIETIN | NEUROSCIENCES | CLINICAL NEUROLOGY | PROGRESSIVE MULTIPLE-SCLEROSIS | REDUCES NEURONAL APOPTOSIS | TRAUMATIC BRAIN-INJURY | PHARMACOLOGY & PHARMACY | NEONATAL HYPOXIA-ISCHEMIA | RED-CELL APLASIA | Neuroprotective Agents - therapeutic use | Brain Diseases - metabolism | Schizophrenia - metabolism | Spinal Cord Injuries - drug therapy | Spinal Cord Injuries - metabolism | Erythropoietin - therapeutic use | Humans | Erythropoietin - adverse effects | Retinal Diseases - metabolism | Stroke - drug therapy | Neurodegenerative Diseases - metabolism | Neurodegenerative Diseases - drug therapy | Peripheral Nerves - drug effects | Erythropoietin - analogs & derivatives | Brain Diseases - drug therapy | Stroke - metabolism | Animals | Nervous System - drug effects | Signal Transduction - drug effects | Receptors, Erythropoietin - drug effects | Erythropoietin - metabolism | Retinal Diseases - drug therapy | Schizophrenia - drug therapy | Neurons - drug effects | Nervous system diseases | Multiple sclerosis | Erythropoietin | Analysis | Schizophrenia | Cognition | Health aspects | Medical research | Nervous system | Review
Journal Article